Preliminary Results of a Phase 2 Trial of Obinutuzumab, in Combination With Ifosfamide, Carboplatin and Etoposide (OICE) in Children, Adolescents and Young Adults With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
10-2022
Journal Title
Leukemia Research
Department
Pediatrics
Second Department
Medicine
Third Department
Public Health
Recommended Citation
Hochberg, J., Cohen, M., Barth, M., Harrison, L., Klejmont, L., Shi, Q., Goldman, S., Galardy, P., Perkins, S., Miles, R., Lim, M., & Cairo, M. S. (2022). Preliminary Results of a Phase 2 Trial of Obinutuzumab, in Combination With Ifosfamide, Carboplatin and Etoposide (OICE) in Children, Adolescents and Young Adults With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma. Leukemia Research, 121, S62-S63. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/767
COinS
